UPDATE 1-Fresenius snaps up Akorn, Merck KGaA's biosimilars in separate deals
April 24, 2017 at 18:30 PM EDT
* Akorn deal backed by target's management, key shareholder (Adds Fresenius chief quotes, deal details, background)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.